江苏奥赛康药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
116
NMPA:116
Drug Approvals
Trifluridine and Tipiracil Hydrochloride Tablets
- Product Name
- 曲氟尿苷替匹嘧啶片
- Approval Number
- 国药准字H20253172
- Approval Date
- Jan 14, 2025
NMPA
Trifluridine and Tipiracil Hydrochloride Tablets
- Product Name
- 曲氟尿苷替匹嘧啶片
- Approval Number
- 国药准字H20253171
- Approval Date
- Jan 14, 2025
NMPA
Neratinib Maleate Tablets
- Product Name
- 马来酸奈拉替尼片
- Approval Number
- 国药准字H20249180
- Approval Date
- Oct 22, 2024
NMPA
Fosaprepitant Dimeglumine for Injection
- Product Name
- 注射用福沙匹坦双葡甲胺
- Approval Number
- 国药准字H20244156
- Approval Date
- Jun 25, 2024
NMPA
Isavuconazonium Sulfate for Injection
- Product Name
- 注射用硫酸艾沙康唑
- Approval Number
- 国药准字H20243631
- Approval Date
- Apr 30, 2024
NMPA
Toremifene Citrate Tablets
- Product Name
- 枸橼酸托瑞米芬片
- Approval Number
- 国药准字H20243050
- Approval Date
- Jan 16, 2024
NMPA
Eltrombopag Olamine Tablets
- Product Name
- 艾曲泊帕乙醇胺片
- Approval Number
- 国药准字H20243005
- Approval Date
- Jan 9, 2024
NMPA
Dexlansoprazole for Injection
- Product Name
- 注射用右兰索拉唑
- Approval Number
- 国药准字H20240001
- Approval Date
- Jan 9, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found